Here you will find Dynamic42 GmbH news published in the press as well as pictures and flyers for your editorial use. Browse through the download area, subscribe to our newsletter or contact us!
Read here in which articles and contributions Dynamic42 was reported:
Ohio Lumex, a recognized leader in analytical solutions, is proud to announce a new partnership with German biotechnology company Dynamic42. Effective immediately, Ohio Lumex will serve as the exclusive distributor of Dynamic42’s innovative organ-on-chip technology in the United States.
Read MoreDynamic42 and Heinrich Heine University have developed a tumour-on-a-chip model that replicates the microenvironment of pancreatic ductal adenocarcinoma (PDAC). This 3D model allows for realistic drug testing and could accelerate the development of personalized therapies.
Read MoreDynamic42, in collaboration with ESQlabs, Bayer, and the Placenta Lab, has developed an innovative three-organ system with the potential to reduce animal testing in pharmaceutical research.
Read MoreWe were interviewed by the Ostthüringer Zeitung on the subject of animal-free research.
Read MoreDynamic42 has launched the "Online Academy" for learning Organ-on-Chip technology as an alternative to animal testing.
Read MoreImproving people's lives with innovative technologies. This was the goal that Jena-based Dynamic42 had in mind 18 months ago when they launched a project - funded as part of the Sanofi iDEA-iTECH Award Program.
Read More